Losing just ninety minutes of sleep a night could quietly nudge your body toward weight gain, a Columbia University study found

Losing just ninety minutes of sleep a night could nudge your body toward weight gain. See what a Columbia University study ...
Morning Overview on MSN

A new daily pill beat oral Ozempic on weight and blood sugar in a big diabetes trial

A daily pill called orforglipron lowered blood sugar and body weight more than oral semaglutide in a large phase 3 diabetes ...

Study finds offering self-sampling to patients increases HPV detection and cervical cancer screenings

A randomized controlled trial in Singapore found that, compared with offering clinician sampling alone, offering self-sampling or clinician sampling increased both high-risk HPV detection (3.1% vs. 0.
Morning Overview on MSN

ChatGPT is adding a study mode and stronger controls parents can set for teen accounts

OpenAI is rolling out a study mode for ChatGPT alongside tighter parental controls designed specifically for teen accounts.

i-Lumen Scientific Announces First U.S. Patient Randomized in i-SIGHT2 Pivotal Study Evaluating Noninvasive Bioelectric Therapy for Intermediate to Advanced Dry AMD

Lumen Scientific, Inc., a clinical-stage medical technology company developing bioelectric therapies for retinal disease, today announced the first U.S. patient has been randomized in the i-SIGHT2 ...

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial

Half of planned clinical sites will be activated this month; more than 20 patients have been pre-identified across participating centers Company to hold Type D meeting with FDA to discuss a potential ...
The New England Journal of Medicine

Ivermectin to Control Malaria — A Cluster-Randomized Trial

Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...
ascopubs.org

Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer

Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study PD-1 immune checkpoint ...